Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer
- PMID: 29263709
- PMCID: PMC5726358
- DOI: 10.2147/LCTT.S142880
Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer
Abstract
Background: Various biomarkers have been shown to predict prognosis in various types of cancers. However, these biomarkers have not been studied in advanced small cell lung cancer (SCLC). The modified Glasgow prognostic score (mGPS) is based on serum albumin level and C-reactive protein (CRP). The prognostic nutritional index (PNI) is a combination of serum albumin level and absolute lymphocyte count. This study aimed to evaluate the prognostic value of mGPS and PNI in SCLC.
Methods: We retrospectively reviewed and calculated mGPS and PNI for patients with stage IIIB or IV SCLC who initiated platinum-based combination chemotherapy between November 2007 and June 2016. We compared overall survival (OS) and progression-free survival (PFS) between high and low groups of these two biomarkers. Univariate and multivariate Cox hazard analyses assessed the prognostic value of these biomarkers.
Results: We reviewed 97 SCLC patients. The OS of patients with mGPS 0-1 and higher PNI was significantly longer than that of those with mGPS 2 and lower PNI. The PFS of mGPS 0-1 was significantly longer than that of mGPS 2, while there was no significant difference in PFS according to PNI. Multivariate analyses found mGPS 0-1 (hazard ratio [HR] 2.34, 95% confidence interval [CI] 1.27-4.31, P<0.01) and higher PNI (HR 0.50, 95% CI 0.31-0.78, P<0.01) as prognostic factors for longer OS. However, neither biomarker was predictive of PFS.
Conclusion: Our study was a small retrospective study; however, the data demonstrate that pretreatment mGPS and PNI are independent predictors of OS in patients with advanced SCLC. The pretreatment assessment of mGPS and PNI may be useful for identification of patients with poor prognosis. We recommend pretreatment measurement of serum albumin, C-reactive protein, and absolute lymphocyte count.
Keywords: modified Glasgow prognostic score; overall survival; prognostic nutritional index; progression-free survival; small cell lung cancer.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures


Similar articles
-
Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer.BMC Cancer. 2020 Nov 11;20(1):1092. doi: 10.1186/s12885-020-07560-3. BMC Cancer. 2020. PMID: 33176752 Free PMC article.
-
Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.Nutr Cancer. 2021;73(2):230-238. doi: 10.1080/01635581.2020.1749290. Epub 2020 Apr 9. Nutr Cancer. 2021. PMID: 32270713
-
Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.Lung Cancer. 2019 Oct;136:45-51. doi: 10.1016/j.lungcan.2019.08.006. Epub 2019 Aug 14. Lung Cancer. 2019. PMID: 31437663
-
A high Glasgow prognostic score (GPS) or modified Glasgow prognostic score (mGPS) predicts poor prognosis in gynecologic cancers: a systematic review and meta-analysis.Arch Gynecol Obstet. 2020 Jun;301(6):1543-1551. doi: 10.1007/s00404-020-05581-8. Epub 2020 May 14. Arch Gynecol Obstet. 2020. PMID: 32409927
-
Inflammation and nutrition-based biomarkers in the prognosis of oesophageal cancer: a systematic review and meta-analysis.BMJ Open. 2021 Sep 30;11(9):e048324. doi: 10.1136/bmjopen-2020-048324. BMJ Open. 2021. PMID: 34593492 Free PMC article.
Cited by
-
Predicting Overall Survival Using Preoperative Nutritional and Inflammation Status for Colorectal Cancer.In Vivo. 2022 Jan-Feb;36(1):450-457. doi: 10.21873/invivo.12724. In Vivo. 2022. PMID: 34972748 Free PMC article.
-
Baseline prognostic nutritional index and changes in pretreatment body mass index associate with immunotherapy response in patients with advanced cancer.J Immunother Cancer. 2020 Nov;8(2):e001674. doi: 10.1136/jitc-2020-001674. J Immunother Cancer. 2020. PMID: 33219093 Free PMC article.
-
Impact of metabolic and nutritional disorders on the synergy between radiotherapy and immunotherapy in non-small-cell lung cancer.BMC Cancer. 2025 May 27;25(1):948. doi: 10.1186/s12885-025-14278-7. BMC Cancer. 2025. PMID: 40426072 Free PMC article.
-
The prognostic value of pretreatment prognostic nutritional index in patients with small cell lung cancer and it's influencing factors: a meta-analysis of observational studies.J Thorac Dis. 2020 Oct;12(10):5718-5728. doi: 10.21037/jtd-20-1739. J Thorac Dis. 2020. PMID: 33209404 Free PMC article.
-
Prognostic Value of C-Reactive Protein-to-Lymphocyte Ratio in Combined Immunotherapy and Chemotherapy for Small Cell Lung Cancer.J Inflamm Res. 2025 Jul 17;18:9343-9353. doi: 10.2147/JIR.S517816. eCollection 2025. J Inflamm Res. 2025. PMID: 40692548 Free PMC article.
References
-
- McMillan DC. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc. 2008;67(3):257–262. - PubMed
-
- McMillan DC, Crozier JE, Canna K, Angerson WJ, McArdle CS. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis. 2007;22(8):881–886. - PubMed
-
- Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85(9):1001–1005. Japanese. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous